Skip to main content
Clinical Trials/ACTRN12616000838415
ACTRN12616000838415
Suspended
Phase 4

Analgesic effect of adding dexmedetomidine and or nitroglycerin (NTG) to lidocaine for intravenous regional anesthesia in patients scheduled for forearm surgery.

Hoda Alsaid Ahmed Ezz0 sites80 target enrollmentJune 27, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Hoda Alsaid Ahmed Ezz
Enrollment
80
Status
Suspended
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hoda Alsaid Ahmed Ezz

Eligibility Criteria

Inclusion Criteria

  • Eighty patients of both sex, aged (20 \- 60\) years scheduled for hand or forearm surgery, ASA physical status class I and II

Exclusion Criteria

  • Patients with open fractures of upper limb, sickle cell anemia, peripheral vascular insufficiency, cardiac disease, hypertensive patients, liver or, kidney disease, patients who are taking any analgesia within the previous 24 h, or history of drug allergy, will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials